DPP4 and acute kidney injury: Furthermore, the incidence of AKI was significantly less in DPP-4 inhibitor group (25% vs 64%, respectively; P = 0.026), suggesting that DPP-4 inhibitors can attenuate cisplatin-induced AKI (Table 2).